Fractyl Health, Inc. shareholders can lead class action lawsuit over alleged securities fraud
News provided byFractyl Health, Inc · 1 min read
LOS ANGELES, Sept. 4, 2026 /CourierPR/ -- Fractyl Health, Inc. shareholders who suffered financial losses due to alleged securities fraud now have the opportunity to lead a class action lawsuit, according to a press release from Glancy Prongay Wolke & Rotter LLP. The firm is seeking investors who lost money in Fractyl Health, Inc. securities to take action by October 20, 2026.
The lawsuit alleges that between January 13, 2025, and January 29, 2026, Fractyl Health, Inc. and its executives made materially false and misleading statements, and failed to disclose important adverse information about the company's business, operations, and future prospects. Specifically, the complaint claims that the company did not disclose that its key product, Revita, was less effective than previously indicated, and that operational issues at certain clinical sites may have compromised the integrity of the efficacy results. The allegations suggest that these failures led to an overstatement of the product's clinical, regulatory, and commercial potential.
The firm’s reputation is bolstered by its recent achievements. In 2025, GPWR was named one of Law360's Securities Groups of the Year and ranked second in total investor recoveries by Institutional Shareholder Services Securities Class Action Services. The firm's experience spans a wide range of corporate misconduct cases, covering nearly all industries.
For those who have purchased Fractyl Health, Inc. securities during the class period but do not wish to lead the lawsuit, the option to remain an absent class member exists. However, it's important to note that no class has yet been certified.
Glancy Prongay Wolke & Rotter LLP's track record includes significant media coverage in publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, and Forbes. The firm’s successes have been recognized by leading industry publications, underscoring its expertise in securities litigation.
Shareholders are encouraged to act quickly to preserve their rights and potentially recover their losses.